|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.45 USD | -2.22% |
|
-11.75% | +10.99% |
| Market Cap | 3.33B 2.92B 2.73B 2.5B 4.69B 319B 4.8B 32.36B 12.65B 158B 12.49B 12.22B 545B | P/E 2026 * |
-7.2x | P/E 2027 * | -7.84x |
|---|---|---|---|---|---|
| Enterprise Value | 2.71B 2.38B 2.22B 2.04B 3.81B 259B 3.91B 26.31B 10.29B 128B 10.16B 9.94B 443B | EV / Sales 2026 * |
31.8x | EV / Sales 2027 * | 33x |
| Free-Float |
70.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -2.22% | ||
| 1 week | -11.75% | ||
| Current month | -14.21% | ||
| 1 month | -14.90% | ||
| 3 months | +9.61% | ||
| 6 months | +21.39% | ||
| Current year | +10.99% |
| 1 week | 26.19 |  | 30.17 |
| 1 month | 25.68 | | 31.32 |
| Current year | 18.52 | | 31.74 |
| 1 year | 8.84 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 30/04/2015 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 30/04/2015 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 31/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 30/11/2017 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 17/09/2017 |
Yasunori Kaneko
BRD | Director/Board Member | 71 | 30/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Sell | Founder | -20,067 | 0.0160% | ||
| 24/06/26 | Sell | Founder | -6,431 | 0.0051% | ||
| 11/06/26 | Free | Director | 22,600 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.22% | -11.75% | +175.23% | +32.91% | 3.33B | |
| +0.54% | +6.60% | +0.66% | +14.41% | 48.95B | |
| +1.90% | +24.70% | +27.25% | +9.47% | 40.75B | |
| -1.60% | -1.15% | +388.84% | +603.70% | 38.46B | |
| -0.98% | +2.28% | +7.02% | +45.34% | 36.38B | |
| +1.47% | +5.82% | +5.76% | +43.52% | 28.45B | |
| -0.94% | +0.05% | - | - | 16.62B | |
| +2.44% | +10.76% | +30.59% | +129.56% | 16.33B | |
| -1.14% | +6.52% | -3.80% | -29.33% | 13.65B | |
| +0.26% | +4.08% | +4.15% | +9.97% | 13.56B | |
| Average | -0.22% | +4.04% | +70.63% | +95.51% | 25.65B | |
| Weighted average by Cap. | -0.10% | +6.68% | +73.40% | +121.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.06M 74.74M 69.77M 64.03M 120M 8.15B 123M 827M 324M 4.03B 319M 312M 13.94B | 93.06M 81.77M 76.33M 70.05M 131M 8.91B 134M 905M 354M 4.41B 349M 342M 15.25B |
| Net income | -456M -401M -374M -344M -643M -43.71B -659M -4.44B -1.74B -21.63B -1.71B -1.68B -74.78B | -431M -378M -353M -324M -607M -41.24B -622M -4.19B -1.64B -20.41B -1.62B -1.58B -70.54B |
| Net Debt | -621M -546M -510M -468M -875M -59.51B -897M -6.04B -2.36B -29.45B -2.33B -2.28B -102B | -259M -228M -213M -195M -365M -24.84B -374M -2.52B -986M -12.29B -974M -953M -42.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | US$26.45 | -2.22% | 856,162 |
| 28/07/26 | US$27.05 | -2.84% | 1,580,324 |
| 27/07/26 | US$27.84 | -2.04% | 1,268,818 |
| 24/07/26 | US$28.42 | -4.41% | 1,230,517 |
| 23/07/26 | US$29.73 | -0.80% | 1,217,570 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
